8–9am ET
CME/CE Accredited Session
9:10–10:10am ET
CME/CE Accredited Session
Breaking Down Metabolic Liver Disease: A Primary Care Approach to MASLD and MASH
Supported by This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
10:20–11:05am ET
Non-CME Industry Theater
Learn About a Nonhormonal FDA-Approved Treatment for Moderate to Severe Vasomotor Symptoms Due to Menopause.
Sponsored by Astellas Pharma US, Inc.
11:15am–12:15pm ET
CME/CE Accredited Session
Innovations in OSA Management: Tools for Effective Diagnosis, Treatment, and Long-term Success
Supported by Inspire Medical Systems, Inc.
12:25–1:25pm ET
CME/CE Accredited Session
1:35–2:20pm ET
2:30–3pm ET
CME/CE Accredited Session
3:10–4:10pm ET
CME/CE Accredited Session
4:20–4:50pm ET
CME/CE Accredited Session
5–5:45pm ET
Non-CME Industry Theater
Collaborative Care to Improve the Outcomes of Patients with Cardio-Renal-Metabolic Disorders
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC
Customer Help Information
We are here to help. If you need assistance, please contact us through your preferred channel:
Phone: 877-477-4633
(Program Days, Session Open–Session Close)
Email: support@pri-med.com
Online Chat: Enabled During Program Days